Skip to content

Study on Epigenetic Material Basis of TCM Syndrome Types of Type 2 Diabetes Based on lncRNA and Circular RNA Regulatory Network

Study on Epigenetic Material Basis of TCM Syndrome Types of Type 2 Diabetes Based on lncRNA and Circular RNA Regulatory Network

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001132
Enrollment
Unknown
Registered
2025-06-06
Start date
2018-01-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Diabetes of the type caused by dampness and heat stagnating in the spleen:no intervention
Diabetes with deficiency of both qi and yin:no intervention
Healthy:no intervention
Diabetes of the Yin Deficiency and Heat Excess Type:no intervention
Diabetes of Yin-Yang Deficiency Type:no intervention

Sponsors

Beijing University of Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1)T2DM group: subjects with T2DM were included according to the criteria of International Diabetes Federation (IDF 2019) fasting blood glucose (FBG) =7.0 mmol/L glycosylated hemoglobin (HbA1C) =6.5%. Age 40-75 years old; volunteer to participate in this project;(2) healthy control group: normal health results no diabetes and diabetes complications related symptoms; age 35-75 years old; volunteer to participate in this project research.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with FBG greater than 16.7mmol/L in the past month and without standard treatment; gestational diabetes mellitus type 1 diabetes mellitus secondary diabetes mellitus and diabetes of uncertain type; patients with serious primary diseases of heart liver kidney lung brain and other organs; patients with acute diabetic complications such as diabetic ketosis; patients with bleeding tendency in the past month; patients with mental diseases infectious diseases and self-care disability; patients with tertiary hypertension; Subjects with a history of angina pectoris and cardiac insufficiency; recent significant fundus hemorrhage; subjects with hepatic and renal insufficiency or participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
FPG;

Secondary

MeasureTime frame
Glycated hemoglobin;

Countries

China

Contacts

Public ContactJiang Guangjian

Beijing University of Chinese medicine

bucmjiang@163.com+86 186 0091 5770

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026